BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.23.
Share Price | ₹76.9 | May 15,2025 |
Market Cap | ₹182.3 Cr | |
Sales-TTM | ₹148.2 Cr | TTM-Standalone Results |
Price/Sales | 1.23x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹182.3 Cr] as on May 15,2025
(/) Sales [ ₹148.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.23x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.23 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.21x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.05x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BAFNA PHARMACEUTICALS | 148.2 | 1.23 | 182.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.09 | 417,400.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 18.16 | 164,844.0 |
CIPLA LTD | 27,547.6 | 4.40 | 121,328.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.78 | 110,521.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.16 | 103,043.0 |
MANKIND PHARMA LTD | 11,641.0 | 9.07 | 105,632.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.09 | 91,008.8 |
LUPIN LTD | 22,707.9 | 4.17 | 94,583.5 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.29 | 70,683.6 |
ABBOTT INDIA LTD | 6,243.2 | 10.34 | 64,536.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.23x |
Max industry PS | 18.16x |
Median industry PS | 4.40x |
Average industry PS | 6.80x |
You may also like the below Video Courses